Sumitomo Mitsui Trust Group
AHCO icon

Sumitomo Mitsui Trust Group’s AdaptHealth AHCO Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-266,204
Closed -$3.24M – 1135
2023
Q2 		$3.24M Sell
266,204
-3,020,278
-92% -$33.7M ﹤0.01% 874
2023
Q1 		$40.9M Buy
3,286,482
+308,727
+10% +$5.68M 0.03% 557
2022
Q4 		$57.2M Buy
2,977,755
+59,972
+2% +$1.27M 0.05% 454
2022
Q3 		$54.8M Sell
2,917,783
-481,992
-14% -$9.91M 0.05% 456
2022
Q2 		$61.3M Buy
3,399,775
+876,148
+35% +$14.2M 0.05% 432
2022
Q1 		$40.5M Buy
2,523,627
+679,937
+37% +$12.2M 0.03% 593
2021
Q4 		$45.1M Buy
+1,843,690
New +$43.3M 0.03% 572

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Sumitomo Mitsui Trust Group's AHCO Position: Q3 2023 in Review

Sumitomo Mitsui Trust Group sold out of AdaptHealth (AHCO) in Q3 2023, closing a stake of 266,204 shares — an estimated $3.24M sold.

Sumitomo Mitsui Trust Group first reported a position in AHCO in Q4 2021 and held it in 7 quarters. The position peaked at $61.3M in Q2 2022. 191 funds tracked by Wall St. Rank hold AHCO as of Q3 2023.

  • Sumitomo Mitsui Trust Group reported no remaining AdaptHealth position as of Q3 2023 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 266,204 AdaptHealth shares in Q3 2023, an estimated $3.24M.
  • Sumitomo Mitsui Trust Group first reported a position in AdaptHealth in Q4 2021 and held it in 7 quarters.
  • Sumitomo Mitsui Trust Group's AdaptHealth position peaked at $61.3M in Q2 2022.
  • 191 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2023.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2023, filed 30 Oct 2023.